Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm
In emergency situations, such as during the coronavirus disease 2019 (COVID-19) pandemic, medical community looks for quick answers and guidance. Under these circumstances, experts instead of admitting ignorance, feel obliged to give an answer, often pressurized by political or other authorities, ev...
Main Authors: | Filippos Triposkiadis, Konstantinos Dean Boudoulas, Andrew Xanthopoulos, Harisios Boudoulas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Hellenic Journal of Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966620302499 |
Similar Items
-
The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01) -
Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients
by: Anja Pfaue, et al.
Published: (2019-11-01) -
ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
by: Filippos Triposkiadis, et al.
Published: (2021-08-01) -
UPDATES OF THE RENIN‐ANGIOTENSIN‐ALDOSTERON SYSTEM
by: Minela MĂRĂNDUCA, et al.
Published: (2013-07-01) -
Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)